Physician profile
Hector Manuel Gonzalez Garcia
NPI 1528250073
$22,583.85
in general payments reported to CMS, 2019-2025
31 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $87.87 · 2021: $521 · 2022: $560 · 2023: $4,968 · 2024: $2,694 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $2,987 · Travel and Lodging: $2,903 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,950.00 |
| Food and Beverage | $2,987.24 |
| Travel and Lodging | $2,903.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $11,450.00 | 2025 | Heartrail |
| Boston Scientific Corporation | $2,882.48 | 2019-2025 | Accolade Sr, Avvigo Guidance System, Solyx Sis System |
| Abbott Laboratories | $2,500.00 | 2023 | Dragonfly Opstar |
| Axonics, INC. | $1,482.03 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $1,124.75 | 2024 | |
| Coloplast Corp | $707.14 | 2021-2025 | Supris, Altis |
| Sumitomo Pharma America, INC. | $549.55 | 2023-2025 | Gemtesa, Orgovyx |
| Baxter Healthcare | $275.12 | 2021-2024 | Tisseel, Preveleak |
| Astellas Pharma US INC | $253.75 | 2021-2024 | Veozah, Myrbetriq |
| Urovant Sciences INC | $181.34 | 2022 | |
| Caldera Medical, INC | $145.58 | 2024 | Desara |
| Bayer Healthcare Pharmaceuticals INC. | $111.43 | 2022-2025 | |
| Endo USA, INC. | $103.81 | 2024-2025 | Aveed, Xiaflex, Edex |
| Teleflex LLC | $94.98 | 2024-2025 | Urolift, Solesta |
| Immunitybio, INC. | $90.75 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $90.18 | 2022 | |
| Valencia Technologies Corporation | $89.95 | 2023 | Ecoin Device Kit |
| Medtronic, INC. | $72.99 | 2022-2025 | Interstim |
| Ferring Pharmaceuticals INC. | $55.39 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $47.85 | 2022-2023 | Erleada |
| Abbvie INC. | $41.90 | 2024 | |
| Olympus America INC. | $41.25 | 2023 | Itind System |
| Tolmar, INC. | $29.92 | 2023 | |
| Endo Pharmaceuticals INC. | $23.90 | 2024 | Edex, Aveed, Xiaflex |
| Merck Sharp & Dohme LLC | $23.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.61 | 2024 | Xarelto |
| Urogen Pharma, INC. | $22.56 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.15 | 2024 | |
| Hollister Incorporated | $17.26 | 2023 | Infyna Chic, Vapro |
| Progenics Pharmaceuticals, INC. | $15.80 | 2023 | Pylarify |
| Sagent Pharmaceuticals | $14.07 | 2023 | Glydo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Gonzalez Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.